当前位置:首页 > 文献互助 > 互助详情

Safety and Efficacy of the Contact Activation Inhibitor AB023 in Patients with End-Stage Renal Disease on Chronic Hemodialysis: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Trial复制

答案Answerball 13小时前 16 10 求助中 帖子自动结束时间: 2026-04-19 09:03:02

1. 文件大小不能超过300M, 允许上传文档或压缩包等

2. 请确保上传文献的真实性、完整性,不得对原文做任何修改

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1182/blood-2020-139948复制

文献链接: https://ashpublications.org/blood/article/136/Supplement%201/23/469854/Safety-and-Efficacy-of-the-Contact-Activation复制

其他信息:

出版社: American Society of Hematology
作者: Christina U Lorentz; Norah G Verbout; Joseph J Shatzel; Michael Wallisch; Brandon D Markway; Monica T Hinds; Owen J T McCarty; David Gailani; Jeffrey I. Weitz; Erik I Tucker; András Gruber
全文下载地址: https://ashpublications.org/blood/article/136/Supplement%201/23/469854/Safety-and-Efficacy-of-the-Contact-Activation

互助时间线

2026-04-14 09:03:02 [发起求助]